Synergistic therapeutic potential of dexamethasone and L-arginine on acetic acid-induced colitis in albino rats : A histological and immunohistochemical study / Shimaa Ahmed Zaki ; Supervised Hend Shafik Bassiouny , Noha Mohamed Afifi Amin , Marwa Mohamed Yousry
Material type: TextLanguage: English Publication details: Cairo : Shimaa Ahmed Zaki , 2018Description: 203 P. : charts , facsimiles ; 25cmOther title:- التآزر العلاجي المحتمل للديكساميثازون والأرجينين على إلتهاب القولون المحدث بحامض الخليك في الجرذان البيضاء دراسة هستولوجية وهستوكيميائية مناعية [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|---|
Thesis | قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.16.M.Sc.2018.Sh.S (Browse shelf(Opens below)) | Not for loan | 01010110078291000 | |||
CD - Rom | مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.16.M.Sc.2018.Sh.S (Browse shelf(Opens below)) | 78291.CD | Not for loan | 01020110078291000 |
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Histology
Background:Dexamethasone (DEX) is widely used as the first line therapy of ulcerative colitis. However, long term glucocorticoids treatment often results in detrimental side effects. Recent studies suggested that L-arginine (Arg.) may be a promising supplement that maintains mucosal integrity and healing. Aim of the study:To evaluate the synergistic therapeutic effect of combined DEX and Arg. on acetic acid-induced colitis; monitored by histological, immunohistochemical and laboratory methods. Material & Methods: Twenty eight,12 weeks-old-male albino rats were divided into: group I (control), group II (Acetic acid (AA)-treated), group III (AA and DEX-treated), group IV (AA and Arg.-treated) and group V (AA, DEX and Arg.-treated). 2 ml of AA 4% was instilled intracolonic, once daily for 3 consecutive days. DEX was injected intraperitoneally, once daily for one week, at a dose of 2 mg/kg. Arg. was administrated orally, once daily for one week, at a dose of 100 mg. The proximal 3 cm of the descending colon were analyzed for studying expression ofiNOS, NO, TNF-Ü and IL-1Ý. The distal 3 cm of colonic specimens were stained with H&E, Alcian blue and immunohistochemical staining for COX-2. Morphometric measurement and statistical analysis were done. Results:AA-treated group sections revealed massive distortion of colonic wall architecture. Supplementation with DEX and Arg. could preserve the mucosal integrity and inflammatory profile
Issued also as CD
There are no comments on this title.